Testing

Biomarker for GHB Detection Extends Forensic Testing Window

Researchers at the University of Zurich identified GHB-pentose to detect exposure past standard testing limits.

Published November 18, 2026 Read 3 min 560 words Topic Testing
Reviewed by: Dr. Michael Teplitsky, MD · November 2026

How GHB-Pentose Extends the Forensic Testing Window

A newly evaluated biomarker called GHB-pentose remains detectable in urine longer than standard gamma-hydroxybutyrate (GHB) tests allow. The substance GHB leaves the body rapidly after administration, clearing blood within about six hours and urine within 12 hours. Because the drug causes memory gaps and altered consciousness, individuals suspected of being exposed often present for medical evaluation after those standard analytical windows close.

Investigators at the Institute of Forensic Medicine at the University of Zurich, collaborating with the University Hospital of Psychiatry Zurich, first discovered the marker in 2021. The molecule is a conjugate formed between GHB and a pentose sugar, thought to be ribose. While earlier controlled research published in 2025 indicated that GHB-pentose remains detectable in urine for up to three days after ingestion, confirming its behavior in routine forensic practice required direct testing on casework samples.

Evidence From More Than Two Thousand Forensic Samples

Forensic casework confirms that GHB-pentose identifies exposure in cases where parent drug levels fall below standard screening thresholds. In a study published in Drug Testing and Analysis, investigators reviewed 2,414 anonymized urine specimens collected from actual forensic investigations between 2024 and 2026. The research team applied two independent mass spectrometry (MS) techniques to evaluate each specimen.

The team identified GHB-pentose in all 21 samples from living individuals that had tested positive for GHB through conventional screening. More notably, the biomarker appeared in 14 additional samples where parent GHB concentrations sat below the established forensic threshold. Case records corroborated suspected GHB administration in eight of those 14 cases, including two robberies and one alleged sexual assault where clinicians collected urine 13 to 16 hours after the event.

Differentiating Natural Post-Mortem Levels From Prior Ingestion

The GHB-pentose conjugate forms during active metabolic processing and does not appear to accumulate as a byproduct of post-mortem decomposition. The human body produces small quantities of GHB naturally, and tissue degradation after death can also generate elevated levels of the compound. This endogenous generation complicates post-mortem forensic toxicology when investigators attempt to confirm whether a deceased individual ingested the substance prior to death.

Urine analyses from 20 deceased individuals showed elevated GHB concentrations without any detectable GHB-pentose. In four separate post-mortem samples, analysts detected both the parent compound and the biomarker together. These observations suggest that GHB-pentose synthesis requires in vivo metabolic activity prior to death, providing a potential tool to separate post-mortem drug formation from prior administration.

Analytical Methods and Limitations in Current Practice

Forensic laboratories can identify GHB-pentose through established mass spectrometry workflows, although formal diagnostic parameters remain incomplete. The University of Zurich team incorporated the screening directly into two standard toxicology methods, allowing testing without specialized machinery. The laboratory now tests for GHB-pentose routinely whenever casework involves suspected GHB exposure.

Several analytical caveats remain before widespread clinical adoption occurs. First, the exact chemical structure of the pentose conjugate has not been settled conclusively. Second, laboratories currently operate without a commercially available chemical reference standard for precise quantification. Finally, the authors noted that existing data do not establish diagnostic sensitivity figures or the absolute maximum detection window for any single individual, meaning toxicologists must interpret laboratory findings alongside specific case details.

  • The exact chemical structure of GHB-pentose is not yet confirmed conclusively.
  • No commercial reference standard exists for quantitative calibration.
  • Individual detection periods and diagnostic reliability require further controlled study.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.
Primary source: View original source — referenced for fact-checking; this analysis is independent editorial content.
Found this useful?

Related Articles

Want to know what your markers actually mean?

Opt Health publishes a guide to the 55+ biomarkers they test and what each one tells you — the same panel they run before building a treatment plan.

Read Opt Health's biomarker guide →

Topic updates

Get the weekly lab marker roundup

Blood test interpretation, optimal ranges, fasting insulin, A1C, thyroid panels, testosterone, cortisol, and nutrient markers.

No spam. Unsubscribe anytime.

Understand Your Health Better

Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results